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The RNA promoters of the genome and antigenome of Newcastle disease virus (NDV) were studied by mutational analysis of their 3V
terminal ends. Similarly to other paramyxoviruses, NDV RNA replication follows the rule of six, and the genomic and antigenomic
promoters require two discontinuous regions: conserved region I (first 18 nucleotides) and conserved region II (nucleotides 73–90). Proper
spacing between those regions and the phase of six in region II is critical for efficient RNA promoter activity. As expected, the gene start
signal at the 3V end of the NDV genome was required for mRNA transcription, but not for RNA replication. Surprisingly, mutation of the
polyadenylation signal in the 5V end did not affect gene expression transcription. Although the conserved region I of NDV (avulavirus)
promoter appears to be more similar to that of Sendai virus (SeV) (respirovirus), conserved region II is analogous to that of rubulaviruses.
D 2004 Elsevier Inc. All rights reserved.
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Newcastle disease virus (NDV) is a member of the
family Paramyxoviridae and has been recently assigned to
the new genus Avulavirus. NDV strains are grouped
according to the severity of the disease caused in chickens
as lentogenic, mesogenic, and velogenic (Alexander, 1988,
2000; Seal et al., 2000). NDV has a nonsegmented negative-
stranded RNA genome of 15,186 nucleotides in length (de
Leeuw and Peeters, 1999; Krishnamurthy and Samal, 1998;
Phillips et al., 1998), which encodes the nucleocapsid (NP),
phosphoprotein (P), matrix (M), fusion (F), hemagglutinin–
neuraminidase (HN), and large polymerase (L) proteins.
Additional proteins (designated V and W proteins) are
generated in virus-infected cells due to an RNA-editing
event that occurs during transcription of the P gene (Steward
et al., 1993).0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.10.040
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bound to the NP and they are also associated with the P
and L proteins. Together, these components constitute the
ribonucleoprotein complex, which is the active template for
transcription and replication of the viral genome. NDV
RNA transcription and replication are thought to follow the
general model elucidated with prototype paramyxoviruses
such as Sendai virus (SeV) (Lamb and Kolakofsky, 2001).
During transcription, the polymerase enters the ribonucleo-
protein template at the 3V (leader) genomic end and
transcribes the linear array of genes by a stop–start, polar
mechanism to produce subgenomic mRNAs. Transcription
is guided by short conserved sequence motifs that flank each
gene, the gene-start (GS) signal and the termination/
polyadenylation or gene end (GE) signal. RNA replication
occurs when the polymerase changes to a readthrough mode
that produces a full-length encapsidated antigenome, which
in turn is the template for progeny genomes.
The development of minireplicons of negative strand
RNA viruses has provided valuable new tools to investigate
in detail the roles of cis-acting RNA elements involved in05) 396–406
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Sastre and Palese, 1993). In these systems, a plasmid-
derived RNA containing the viral 5V and 3V terminal regions
can be replicated in cells in which the viral replication
proteins are also expressed. For the rhabdoviruses and most
of the paramyxoviruses, including NDV (Peeters et al.,
1999), the NP, P, and L proteins are sufficient to promote
efficient viral replication and transcription, except in the
case of respiratory syncytial virus (RSV), which requires
one additional protein (Collins et al., 1996).
Using SeV minireplicons, it was found that viral RNA
replication was efficient only when the RNA nucleotide
length was divisible by six (brule of sixQ) (Calain and Roux,
1993). This has been attributed to the association of the NP
with exactly six nucleotides. This rule holds for all para-
myxoviruses belonging to the subfamily Paramyxovirinae:
the respiroviruses SeV and human parainfluenza virus 3
(hPIV3) (Durbin et al., 1997; Kolakofsky et al., 1998), the
morbillivirus measles virus (Sidhu et al., 1995), the
rubulavirus SV5 (Murphy and Parks, 1997), and the
avulavirus NDV (Peeters et al., 2000). The genomic and
antigenomic RNA replication promoters of SeV are com-
posed of two discontinuous elements. The first promoting
element (region I) is located in the 1–31 nucleotides most
proximal to the 3V end (Tapparel and Roux, 1996). A second
promoter element (region II) consists of a three times
repeated motif (3V-CNNNNN-5V)3, located at nucleotides
79–96 (Tapparel et al., 1998). The same motif was found to
be important for the promoter of a second respirovirus,
hPIV3 (Hoffman and Banerjee, 2000). By contrast, for the
rubulavirus SV5, region II has been shown to consist of the
motif (3V-NNNNGC-5V)3, at nucleotides 73–90 (Murphy and
Parks, 1999; Murphy et al., 1998). In addition, an enhancer
element (region III) has been identified in the antigenomic
promoter of SV5, nucleotides 51–66 (Keller et al., 2001).
In this manuscript, we have studied the cis-acting
sequences involved in the RNA transcription and replication
events at the 3V terminal ends of the NDV genome and
antigenome. We have conducted a mutational analysis of
these termini using a minigenome containing the NDV
noncoding ends flanking a CAT reporter gene in negative
polarity. The minigenome was expressed from a transfected
plasmid in the presence of NP, P, and L proteins. Our results
have revealed critical cis-acting sequences involved in NDV
RNA replication and/or transcription.Results
Characterization of NDV minigenome replication and
transcription
In order to identify regions of the NDV genomic and
antigenomic promoters involved in RNA replication and
transcription, we expressed NP, P, and L proteins as well as
a CAT minigenome using T7 polymerase expressed by arecombinant vaccinia virus and measured CAT activity. To
confirm that this system conforms to the rule-of-six, as
previously reported (Peeters et al., 2000), we constructed a
panel of six plasmids to encode six minigenomes, called
NDVCAT-X-RT (X = 0–5) that differ in length by a single
nucleotide (Fig. 1). Each minigenome is a short negative-
sense analogue of the NDV genomic RNA in which the
viral genes had been deleted and replaced with a negative-
sense copy of the CAT ORF. The CAT ORF is then flanked
by the 5V and 3V untranslated regions of the NP and L genes,
respectively, as well as by the NP gene start and L gene end
transcription motifs and the 3V leader and 5V trailer termini of
the genomic RNA. The minigenomes are expressed from a
T7 RNA polymerase promoter, and the 3V ends are
generated by inclusion of the hepatitis delta virus ribozyme.
The RNA minigenomes are 979–984 nt long. Transfection
of pT7NDVCAT-X-RT (X = 0–5) and plasmids encoding
the NP, P, and L proteins in COS-7 previously cells infected
with a recombinant vaccinia virus vTF7-3, which expresses
T7-RNA polymerase, resulted in the transcription of the
minigenomes, as indicated by the detection of CAT activity.
Optimal conditions were 1 Ag pT7NDVCAT-X-RT, 2 Ag
pTM1-NP, 1 Ag pTM1-P, and 0.4 Ag pTM1-L, and CAT
expression was dependent of transfection of all plasmids
(data not shown). Of all six constructs, transfection of
pT7NDVCAT5RT, whose length is divisible by 6 (6n),
resulted in the highest level of CAT activity (Fig. 1B).
We also analyzed RNA synthesis by Northern blot. Both
positive-sense RNAs (mini-antigenome and subgenomic
CAT mRNA) and negative-sense RNAs (minigenome)
were detected using double-stranded CAT riboprobes for
hybridization in the Northern blots. A discrete band
corresponding to the minigenome and antigenome and a
diffuse smear of subgenomic mRNA of heterogeneous size
was detected in vTF7-3-infected cells after transfection
with pT7NDVCAT5RT (6n) and the NP, P, and L expression
plasmids (Fig. 2A). By contrast, in pT7NDVCAT4RT (6n-
1)-transfected cells, RNA synthesis was significantly
reduced with respect to pT7NDVCAT5RT. Samples in
which the L plasmid was omitted did not have detectable
CAT RNA, indicating that primary T7 transcription of the
minigenome results in undetectable RNA levels by Northern
blot under the used conditions. Only after long periods of
exposure, it was possible to detect the RNA signal due to
primary T7 RNA transcription (data not shown). Thus, our
experiments appear to mimic transcription and replication of
the NDV genome since efficient CAT expression and RNA
synthesis are dependent of expression of NP, P, and L
proteins and follow the rule of six, as expected (Peeters et al.,
2000).
Minimal regions at the 3V and 5V ends of the NDV genome
required for RNA replication and transcription
To identify regions in the NDV RNA promoters
involved in RNA synthesis, we performed a systematic
Fig. 1. (A). Schematic structure of the plasmids encoding the NDV minigenomes. Plasmids pT7NDVCAT-X-RT (X = 5–0) differ in 1 nt in size, and only
pT7NDVCAT5RT encodes a minigenome divisible by six, as indicated. Transcription from the plasmids is directed by a T7 RNA polymerase promoter
(T7). The primary transcript is negative sense and contains from 5V to 3V trailer (TR), gene end (GE), L mRNA 3V untranslated region (3VUTR-L), small
linker, CAT ORF, NP mRNA untranslated region (5VUTR-N), gene start (GS), and viral leader (LE) regions. The positions of the hepatitis delta virus
ribozyme (RZ) and the T7 RNA polymerase transcription termination (Ter) are also indicated, as well as the sequence of the first 91 and 94 nt of the
genomic and antigenomic 3V noncoding regions, which contain the corresponding RNA promoters of the Del3.3 and Del5.3 RNAs. (B) Expression of
CAT enzyme by NDVCAT-X minigenomes. Cells were transfected with pT7NDVCAT-X-RT (X = 0–5) and NP, P, and L protein expression plasmids.
Cells were also infected with recombinant vaccinia virus vTF7-3 expressing T7 RNA polymerase. Lysates were prepared 48 h posttransfection and CAT
activity was measured.
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NDVCAT5 minigenome. Since NDV genome replication
is more efficient when the genome length is multiple of
six, our deletions were designed to give rise to
minigenomes whose length was divisible by six. The 3V
untranslated end of the NDV genome, containing the
genomic promoter, is 121 nt long. Deletions of nt 98–121
(Del3.1) did not affect the levels of CAT activity (Fig.
3A). By contrast, deletion of 12 more nt (86–121, Del3.2)
resulted in low levels of CAT activity (3.17% relative to
NDVCAT5). Inclusion of six more nt (Del3.3) restored
the levels of CAT activity. Therefore, the first 91 nt of the
NDV genomic promoter are able to support RNA
replication and transcription, and nt 86–91 (in hexamers
15 and 16) contain an important region required for
promoter activity.The 5V untranslated end of the NDV genome,
containing the antigenomic promoter, is 191 nt in
length. The NDVCAT5 minigenome includes those 191
nt plus the last five nucleotides of the L coding
sequence (Fig. 1A). A deletion from the nt 101 to the
nt 191 (Del5.1) did not reduce the levels of transcription
and replication of the minigenome, as monitored by
CAT activity (Fig. 3B). By contrast, a deletion from nt
83–191 (Del5.2) abrogated CAT activity, indicating the
presence of an essential RNA region between nt 83 and
100, including hexamers 15 and 16 and portion of the
hexamers 14 and 17 of the antigenome promoter (Fig.
1A). Further mapping of this region indicated that
elimination of nt 95–191 (Del5.3) did not affect CAT
activity, while the deletion of six more nt (89–191,
Del5.4) reduced CAT activity to 7.67% of the
Fig. 2. Detection of RNA synthesis form NDV minigenomes by Northern blot. Cells were transfected and infected with plasmids encoding wild-type or mutant
minigenomes and NP, P, and L expression plasmids. At the same time, cells were infected with recombinant vaccinia virus vTF7-3 expressing T7 RNA
polymerase. A negative control sample was included in which pT7NDVCAT-5-RT was transfected with NP and P, but not L, expression plasmids (no L). (A)
Synthesis of RNA from NDVCAT-X minigenomes. (B–D) Synthesis of RNA from selected NDV minigenomes containing mutated hexamers at the 3V and 5V
ends (E) Synthesis of RNA from NDV minigenomes containing deletions and insertions at the 3V end. (F) Synthesis of RNA from NDV minigenomes
containing specific mutations at hexamers 13, 14, and 15 of the 3V end.
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the first 94 nt of the NDV antigenomic promoter are
efficiently able to support RNA replication and tran-Fig. 3. Effect of deletions in the NDV minigenome on CAT activity. Cells were tran
proteins. At the same time, cells were infected with recombinant vaccinia viru
posttransfection and CAT activity was measured. Activities are expressed relative t
at the 5Vend, antigenomic promoter.scription, and that nt 89–94 (also in hexamers 15 and
16) contain an important region required for promoter
activity.sfected with plasmids encoding the indicated minigenomes and NP, P, and L
s vTF7-3 expressing T7 RNA polymerase. Lysates were prepared 48 h
o NDVCAT5. (A) Deletions at the 3V end, genomic promoter. (B) Deletions
F. Marcos et al. / Virology 331 (2005) 396–406400Hexamers at the 3V end of the NDV genome important in
RNA replication and transcription
The first 91 nt of the 3V genomic promoter is composed
of 15 hexamers (nt 1–90) and 1 nt (nt 91). To further define
the RNA regions involved in promoting transcription and
replication, we exchanged each hexamer in the Del3.3
minigenome for an unrelated sequence (Table 1). For
example, Muthex3.6 RNA contains a change of the 6 nt in
hexamer 6 of the 3V end of the Del3.3 minigenome. The
results using these mutated minigenomes are represented in
Fig. 4A. Mutations of the first three hexamers (3.1, 3.2, and
3.3) resulted in more than 50 times reduction in CAT
activity. Mutations of hexamers 3.4–3.12 had moderate or
not effect in the activity, except for mutations in hexamers
3.10 and 3.11, that significantly decreased the levels of
CAT activity. Hexamers 3.10 and 3.11 contain the predicted
gene start signal of the NP (Fig. 1A). Finally, the sequence
of hexamers 3.13, 3.14, and 3.15 was critical for CAT
activity.
The amount of transcription and replication of selected
mutants was also measured by Northern blots (Figs. 2B
and C). The amount of total RNA detected after trans-
fection of Muthex3.8 was similar to that of NDVCAT5. By
contrast, the amount of RNA detected from Muthex3.13
was reduced several fold as compared to NDVCAT5. No
RNA was detected after transfection of Muthex3.1,
Muthex3.2, Muthex3.3, Muthex3.14, and Muthex3.15.
Thus, the amount of RNA detected by Northern blot
correlated with CAT activity. In the case of Muthex3.10,
affecting the start signal of NP, the signal corresponding to
the minigenome and mini-antigenome size RNAs was not
affected, but the levels of subgenomic mRNA were
significantly reduced, indicating that hexamer 10 isTable 1
Mutations of the hexamers of the 3V end of the NDV genome and CAT
activity
Mutants Nt changesa Percentage of CAT
activityb
Muthex3.1 UGGUUU to CAACCC 0
Muthex3.2 GUCUCU to ACAGAG 0
Muthex3.3 UAGGCA to GCUUUG 1.40 F 0.28
Muthex3.4 UUCCAU to GGAUGC 41.92 F 11.13
Muthex3.5 GCAAUU to AUGGCC 51.35 F 9.49
Muthex3.6 UUUCGC to GGGAUA 63.58 F 13.21
Muthex3.7 UUCCUC to GGAAGA 89.31 F 12.22
Muthex3.8 GUUAAC to UGAUCA 84.97 F 15.39
Muthex3.9 UUCAGC to GGAGUA 85.01 F 13.25
Muthex3.10 GUGCCC to ACAUUU 29.70 F 9.32
Muthex3.11 AUCUUC to GGAGGA 7.60 F 3.99
Muthex3.12 CACACU to UGUCUC 81.29 F 7.69
Muthex3.13 UAGAGC to GCUCUA 18.41 F 5.03
Muthex3.14 UCACGC to GUCUAU 1.11 F 0.69
Muthex3.15 UCGGGC to CAUUUA 0.17 F 0.51
a The hexamer sequences are written in direction 3V–5V.
b Relative CAT activity as compared to NDVCAT5.important for RNA transcription, but no for RNA
replication.
In conclusion, the regions more critical for RNA
replication and transcription in the NDV genomic promoter
fall in the first 18 nt (region I) and in nt 71-90 (region II)
of the 3V end. The gene start signal is important for
synthesis of mRNA (transcription), but not for RNA
replication.
Hexamers at the 5V end of the NDV genome important in
RNA replication
A similar mutagenesis analysis was performed of
hexamers at the 5V end of the NDV minigenome, containing
the antigenomic promoter. For this purpose, we mutated
Del5.3 plasmid, containing the minimal region at the 5V end
required for efficient NDV RNA replication and tran-
scription. This region consisted on 15 hexamers (nt 1–90)
and four extra nt (nt 91–94). When the last 4 nt of the 3V end
of the antigenome promoter in Del5.3 were mutated to an
unrelated sequence (3V-UCAG-5V to 3V-CUGU-5V), CAT
activity after transfection in cells expressing N, P, and L was
similar to that of wild-type NDVCAT5 RNA (data not
shown). Mutations introduced in each of the 15 hexamers
are shown in Table 2, and the effects of these mutations in
CAT activity are graphically represented in Fig. 4B.
Similarly to the genomic promoter, mutations of three first
three hexamers and of hexamers 13, 14, and 15 resulted in a
significant decrease in RNA synthesis, detected by a
reduction in CAT activity. Surprisingly, the end signal of
the L gene (polyadenylation signal) that is predicted to fall
in hexamers 10 and 11 (Fig. 1A) was not required for
efficient CAT activity. Similar results were obtained when
transfections were performed in BRS-T7 cells, constitu-
tively expressing T7 RNA polymerase, in the absence of
recombinant vaccinia virus. These results suggest that
mRNA polyadenylation is not critical for the expression
of NDV-like transcripts. The levels of RNA synthesis of
selected mutants was also measured by Northern blot. RNA
levels correlated with CAT activity (Figs. 2C and D).
Therefore, the regions more critical for RNA synthesis in
the NDV antigenomic promoter, similarly to the genomic
promoter, are in the first 18 nt (region I, hexamers 1–3) and
in nt 71–90 (region II, hexamers13–15).
Effect of insertions and deletions between regions I and II of
the genomic promoter of NDV
In order to elucidate whether the nt distance between
the NDV genomic promoter regions I and II influences
RNA synthesis activity, we inserted one (3V-GGUACC-5V)
or two (3V-GGUACCUACUGC-5V) extra hexamers
between hexamers 7 and 8 of the Del3.3 RNA to generate
Ins6nt-hex7/8 and Ins12nt-hex7/8 RNAs. Insertion of one
hexamer did not affect CAT activity after transfection,
while insertion of 12 nt abolished the CAT activity (Fig. 5).
Fig. 4. Hexamers in the NDV minigenome required for CAT activity. Cells were transfected with plasmids encoding the indicated minigenomes and NP, P, and
L proteins. At the same time, cells were infected with recombinant vaccinia virus vTF7-3 expressing T7 RNA polymerase. Lysates were prepared 48 h
posttransfection and CAT activity was measured. Activities are expressed relative to NDVCAT5. (A) Effect of mutations of hexamers in the genomic promoter,
at the 3V end of the NDV viral RNA (mutations are indicated in Table 1). (B) Effect of mutations of hexamers in the antigenomic promoter, at the 5V end of the
NDV viral RNA (mutations are indicated in Table 2).
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hexamers 12 and 13 (Ins4nt-hex12/13) resulted in approx-
imately four times reduction of CAT activity, despite the
presence of a second insertion of 2 nt (3V-AU-5V) after
position 91 in the RNA that makes it divisible by six. In
addition, Delhex3.7 RNA, in which hexamer 7 was
deleted, was also unable to be amplified by the NDV
RNA polymerase. Analysis of RNA synthesis by Northern
blot confirmed a decrease in RNA synthesis by the mutant
Ins4nt-hex12/13 and Delhex3.7 minigenomes (Fig. 2E).
Therefore, insertions or deletions resulting in a change in
spacing between regions I and II or in the phase of six ofTable 2
Mutations of the hexamers of the 3V end of the NDV antigenome and CAT
activity
Mutants Nt changesa Percentage of CAT
activityb
Muthex5.1 UGGUUU to CAACCC 2.58 F 3.64
Muthex5.2 GUUUCU to UCCGAG 0
Muthex5.3 AAACCA to GGGUUG 4.78 F 3.29
Muthex5.4 CUUACU to UGGGUG 47.12 F 10.57
Muthex5.5 GUUCUG to AGAUCU 78.23 F 15.21
Muthex5.6 AUGUGA to GCACUC 81.61 F 5.29
Muthex5.7 GUUCUU to ACGAGG 87.45 F 12.67
Muthex5.8 AUUGAC to GCCAGU 88.58 F 10.91
Muthex5.9 ACGCGU to AGAUCA 94.37 F 5.34
Muthex5.10 UAGAAA to GCUCCC 74.23 F 6.94
Muthex5.11 AAGAUU to CCUCGG 93.10 F 6.34
Muthex5.12 CUGUAA to ACACGG 78.60 F 10.92
Muthex5.13 AUAAAC to CGCGCA 36.66 F 6.32
Muthex5.14 UCAAGC to GUGGUA 1.23 F 1.01
Muthex5.15 UCAAGC to GACGUA 7.09 F 4.21
a The hexamer sequences are written in direction 3V–5V.
b Relative CAT activity as compared to NDVCAT5.region II in the 3V genomic promoter of NDV affected
promoter activity.
Sequence requirements for promoter activity of hexamers
13, 14, and 15
Hexamers 13, 14, and 15 (region II) are required for the
promoter activity of the NDV RNA (Fig. 4). A sequence
comparison between these hexamers at the genomic and
antigenomic promoters is shown in Fig. 6A. Interestingly,
genomic and antigenomic hexamers 14 and 15 begin by UC
and end by GC. By contrast, the only nt in common of
hexamers 13 with the other hexamers is a C at the 5V end.Fig. 5. Effect of insertions and deletions between the two regions of the
genomic promoter of NDV required for RNA replication and transcription.
Cells were transfected with plasmids encoding the indicated minigenomes
and NP, P, and L proteins. At the same time, cells were infected with
recombinant vaccinia virus vTF7-3 expressing T7 RNA polymerase.
Lysates were prepared 48 h posttransfection and CAT activity was
measured. Activities are expressed relative to NDVCAT5.
Fig. 6. Effect of mutations at hexamers in region II of the genomic RNA promoter of NDV. (A) Sequence alignment of the promoter region II of the genome
and antigenome of NDV. Conserved nucleotides are shown in bold. (B) Mutations inserted in the hexamers 13, 14, and 15 of the NDV genomic promoter.
Hexamers are written in direction 3V–5V. The underlined nucleotides were changed. (C) CAT activity detected after transfection of mutated Del3.3 NDV
minigenomes. Cells were transfected with plasmids encoding the indicated minigenomes and NP, P, and L proteins. At the same time, cells were infected with
recombinant vaccinia virus vTF7-3 expressing T7 RNA polymerase. Lysates were prepared 48 h posttransfection and CAT activity was measured. Activities are
expressed relative to NDVCAT5.
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15 genomic hexamers in Del3.3 RNA (Muthex3.13-Tri,
Muthex3.14-Tri, and Muthex3.15-Tri; Fig. 6B). As shown
in Fig. 6C, first four columns, these mutations did not have a
significant effect in promoter activity. RNA analysis in cells
transfected with Muthex3.14-Tri RNA confirmed these
results (Fig. 2F).
The other last 3 nt of hexamers 13, 14, and 15 at the
genomic promoter were mutated individually (Fig. 6B). For
example, Muthex3.14-nt(5) denotes a mutation of the 5th nt
of hexamer 14 of 3V end of the Del3.3 RNA, in direction 3V–
5V. For hexamers 14 and 15, the last 2 nt (GC) were critical
for RNA synthesis since CAT activity was approximately
fivefold reduced by single point mutations at these positions
(Fig. 6C). For hexamer 13, only the last nt (C) was
important, although not as important as the same nt in
hexamers 14 and 15. Analysis of NDV RNA in transfected
cells confirmed these results (Fig. 3F). Therefore, the NDV
RNA promoter requires an internal repeated 3V-NNNNGC-
5V sequence motif at hexamers 14 and 15 and a C at the 5V
end of hexamer 13 for efficient RNA synthesis.Discussion
A number of factors are known to be important for the
transcription and replication of NDV RNA. Peeters et al.
(1999) first described that, as with other paramyxoviruses,
with the exception of RSV, the NDV NP, P, and L proteins
were necessary and sufficient for efficient RNA tran-
scription and replication. Analysis of nucleocapsids fromSeV (genus Respirovirus) by means of electron microscopy
led to conclude that each NP subunit was associated with
exactly six nucleotides of the genomic RNA (Egelman et al.,
1989). Studies with SeV minigenomes and DI particles led
to the remarkable finding that for efficient viral RNA
replication, the RNA nucleotide length should be divisible
by six, a requirement known as the rule of six (Calain and
Roux, 1993). All known members of the subfamily Para-
myxovirinae have genome sizes that are multiple of 6, and
this would suggest that the rule of six is applicable to all
these viruses. Strict adherence to rule of six has been show
for SeVand measles virus (genus Morbillivirus) (Radecke et
al., 1995), but to a lesser extent for SV5 (genus Rubulavi-
rus) (Murphy and Parks, 1997). This rule apparently does
not apply to members of the subfamily Pneumovirinae
(Samal and Collins, 1996). Our results using minigenomes
derived from NDV (genus Avulavirus) show that NDV
RNA replication follows the rule of six, but that this is not
an absolute requirement (Fig. 1B). These results are in
agreement with those of Peeters et al. (2000), who also
reported that optimal NDV RNA replication requires a
minigenome divisible by six, although this rule is less strict
using preformed RNPs. The requirement of the rule of six
for optimal RNA replication might be the result of a need of
a precise bin phaseQ covering of the RNA promoters of
paramyxoviruses by their NPs to be able to be recognized
by the RNA polymerase during initiation of RNA synthesis
(Calain and Roux, 1993).
To further investigate the RNA signals required for
transcription and replication of the NDV genome, we
have conducted a mutational analysis of the 3V and 5V
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on RNA synthesis and gene expression. Our results have
shown that, similarly to other paramyxoviruses, functional
NDV genomic and antigenomic promoters require two
discontinuous regions: conserved region I consisting in
the first 18 nt and conserved region II consisting in nt
73–90.
Alignment of the conserved region I of the genomic
promoter of NDV (avulavirus) with those of another
paramyxoviruses (Fig. 7A) indicates a closer sequence
identity of the fist 12 nt to those of the conserved region I
of respiroviruses (SeV, HPIV3) or morbilliviruses (MeV)
than to those of rubulavirus (SV5, MuV, HPIV2). The first
12 nt of the NDV antigenomic promoter are identical to
those of the genomic promoter, except for nt 9. Conserved
region I may be important as a nucleation site for
encapsidation of the nascent replication product. But also
these terminal nucleotides may be the location at which the
viral polymerase interacts with the template RNA. When we
substituted the first three hexamers of both the genomic and
antigenomic promoters by a different sequence, RNA
synthesis was greatly affected.
Conserved region II is located at nt 73–90 of the NDV
genomic and antigenomic promoter, and this region is
located at the end of the minimal NDV promoter. Thus, the
minimal sequences at the 3V and 5V ends of the NDV
minigenome required for expression of a reporter gene by
the viral polymerase are approximately 90 nt in length.
Minigenomes developed for other paramyxoviruses, such as
SeV (Park et al., 1991), MeV (Sidhu et al., 1995), HPIV3
(De and Banerjee, 1993), or SV5 (Murphy et al., 1998) also
retained at least 90 nt of the 3V termini of the genome and
antigenome. Mutations of the three hexamers comprised byFig. 7. Sequence alignment of the promoter elements of the genomic RNA of p
morbillivirus groups. (A) The first 18 nt (conserved region I) of the genomic RNA
or C of the conserved region II important for RNA promoter activity are underlinnt 73–90 of the NDV RNA promoters dramatically reduced
RNA replication and transcription (Figs. 2B, D and 4).
Although mutations of hexamers between the conserved
regions I and II had only moderate or no effects in RNA
promoter activity, these hexamers function as a spacer
region. In addition, the gene start signal at the 3V end of the
NDV genome was required for mRNA transcription, but not
for RNA replication (Fig. 2C). Surprisingly, mutation of the
polyadenylation signal in the 5V end of the NDV genome did
not affect gene expression transcription (Fig. 4B). The
possibility that the helper vaccinia virus added a polyA tail
to the transcripts was excluded since we obtained the same
results in cells constitutively expressing T7 RNA polymer-
ase (data not shown). Therefore, it appears that NDV-like
transcripts without polyA tail are translated with the same
efficiency than transcripts with polyA tail. Of note, the RNA
transcripts generated by expressing NP, P, and L proteins
using the polyadenylat ion mutant minigenome
(muthex5.10) appeared shorter than those derived from
wild-type minigenomes (Fig. 2C), and that might suggest
the absence of a polyA tail.
NDV RNA synthesis was not inhibited by the insertion
of 6 nt at positions 42–43 of the minigenomic RNA
(between hexamers 7 and 8). It has been reported that
SV5 RNA replication was inhibited by changes of as little as
six bases in length between conserved regions I and II
(Murphy et al., 1998). By contrast, SeV genomes tolerated
insertions of six bases at position 47 or 67. Nevertheless
SeV genomes containing 12 bases insertions at this region
were defective for replication (Pelet et al., 1996). In the case
of NDV, insertion of 12 nucleotides at position 42 and
deletion of the hexamer 7 in the 3V end of the genomic RNA
inhibited RNA promoter activity. Also, insertions of fouraramyxoviruses belonging to the avulavirus, rubulavirus, respirovirus, and
(listed 3V–5V). (B) The nt 70–96 of the genomic RNA. The conserved nt GC
ed.
F. Marcos et al. / Virology 331 (2005) 396–406404bases between hexamer 12 and 13 and two bases after nt
91, to compensate for the rule of six, inhibited notably
RNA transcription and replication (Figs. 2E and 5).
Therefore, it appears that a proper spacing between
conserved regions I and II and the phase of six of
conserved region II are critical for efficient RNA promoter
activity. These requirements are in agreement with a
nucleocapsid structure similar to the SeV nucleocapsid
model derived from electron microscopy studies. The SeV
nucleocapsid is thought to exist as a left-handed helix, each
turn of the nucleocapsid helix containing 13 NP subunits
associated with precisely 6 nt (Egelman et al., 1989). In this
model, nt 1–18 (conserved region I) and nt 73–90
(conserved region II) are aligned on the same face of the
helix (Le Mercier et al., 2003; Murphy et al., 1998). Both
regions then may form a single recognition and docking site
for binding of the viral polymerase.
We also studied the sequence requirement of hexamers
13, 14, and 15 (conserved region II) of the NDV RNA
promoter. For SeV (respirovirus) copyback DI genomes, it
has been shown that RNA replication required the sequence
(3V-CNNNNN-5V)3 located at nt 79–96 of the genomic and
antigenomic promotes (Tapparel et al., 1998). Analogous
motifs are found at the 3V and 5V ends of other para-
myxovirus, such as HPIV3 (respirovirus) and MeV (mor-
billivirus) (Fig. 7B). In the case of HPIV3, the conserved
motifs (3V-CNNNNN-5V)3 were also shown to be critical for
promoter activity (Hoffman and Banerjee, 2000). By
contrast, conserved region II in SV5 (rubulavirus) consists
on the motif (3V-NNNNGC-5V)3 at nt 73–90 of the RNA
promoter (Murphy and Parks, 1999). All rubulaviruses have
a conserved dinucleotide 3V-GC-5V repeat in hexamers 13,
14, and 15 (Fig. 7B). Although the conserved region I of
NDV (avulavirus) promoter is more similar to SeV
(respirovirus) and MeV (morbillivirus), conserved region
II is analogous to that of rubulaviruses. In addition, like
SV5, the 3V-GC-5V dinucleotides at the end of hexamers 14
and 15 were more sensitive to changes than the same
dinucleotide in hexamer 13, especially with respect to the
penultimate G nt (Fig. 6C). Interestingly, hexamer 13 in the
antigenomic promoter does not contain a G at its penulti-
mate position (Fig. 6A). The fact that the sequence of
hexamer 13 is less important in promoter activity that
hexamers 14 and 15 may also explain that insertion of 6 nt
between regions I and II in the genomic promoter did not
greatly affect RNA replication. This insertion results in a
new region II still characterized by hexamers 14 and 15
(previously 13 and 14) containing the dinucleotide 3V-GC-5V
at their ends.
Since in paramyxoviruses, encapsidation of the nascent
chain by NP is tightly coupled to RNA synthesis, the
conserved region II of paramyxovirus promoters may be
required as a nucleation site for RNA encapsidation or for
viral polymerase binding. The bipartite nature of the RNA
promoter of NDV shown in this manuscript is in agreement
with the general model proposed for initiation of RNAreplication in paramyxoviruses (Lamb and Kolakofsky,
2001).Materials and methods
Cells and viruses
Cells (HeLa and COS-7, obtained from the American
Type Culture collection) were maintained in Dulbecco’s
modified Eagle’s medium (DMEM), supplemented with
10% fetal calf serum (FCS), 2 mM glutamine and penicillin/
streptomycin. BSRT7 cells, constitutively expressing T7
polymerase, were maintained in the same medium with 1
mg/ml of gentamicin and were kindly provided by Dr. M.
Schnell. The recombinant vaccinia virus expressing T7
RNA polymerase (vTF7-3) was kindly provided by Dr. E.
Berger (Fuerst et al., 1986).
Construction of minigenome plasmids
Minigenome plasmids were constructed containing the 3V
leader and 5V trailer regions of NDV strain California,
flanking a chloramphenicol acetyl-transferase (CAT)
reporter gene in negative sense (Fig. 1). The 3V noncoding
region was amplified by PCR using viral RNA as template
and a primer annealing to the first 22 nt of the 3V end of NDV:
5V-ggccgagctcgaagacgcACCAAACAGAGAATCCG-
TAAGG-3V (SacI site in bold, BbsI site underlined, and
annealing nt in capital letters); and a second primer
containing nt 124–105 of the 3V end: 5V-cgcggtcgacggtggta-
tacccagtgatttttttctcCATGTTGGTAGAAGGCTTTC-3V,
(SalI site in bold, the first 36 nt of the CAT ORF in negative
polarity in italics, ATG underlined, and annealing nt in
capital letters). The PCR product was digested using SacI
and SalI restriction enzymes and cloned into SacI/SalI-
digested pIVACAT/S, containing the CAT ORF flanked by
the 3V and 5V ends of the influenza A virus NS gene (Piccone
et al., 1993). The resulting plasmid was named pCAT/
3VNDV/5VFLU. To clone the 5V noncoding region down-
stream the CAT ORF, a PCR was done using a primer
containing the last 23 nt of the 5V end of the genome of
NDV preceded by a truncated T7 promoter: 5V-ggccaagct-
taatacgactcactataACCAAACAAAGATTTGGTGAATG-3V
(HindIII site in bold, truncated T7 promoter in italics,
annealing nt in capital letters), and one of the following six
primers, differing by 1 nt in length: 0-5V-gcgcagatctCGA-
CAATCACATATTAATAGG-3V; 1-5V-gcgcagatctAC-
GACAATCACATATTAATAGG-3V; 2-5V-gcgcagatct
AACGACAATCACATATTAATAGG-3V; 3-5V-gcgca-
gatctTAACGACAATCACATATTAATAGG-3V; 4-5V-
gcgcagatctTTAACGACAATCACATATTAATAGG-3V;
5-5 V-gcgcagatctCTTAACGACAATCACATATTAA-
TAGG-3V (BglII site in bold, L stop codon underlined,
and annealing nt to the NDV sequences downstream the
L ORF in capital letters). The PCR products were
F. Marcos et al. / Virology 331 (2005) 396–406 405digested using HindIII and BglII enzymes and cloned
into HindIII/BglII-digested pCAT/3VNDV/5VFLU. The
result ing plasmids were named pT7NDVCAT0,
pT7NDVCAT1, pT7NDVCAT2, pT7NDVCAT3,
pT7NDVCAT4, and pT7NDVCAT5.
To add the ribozyme sequence of the hepatitis delta virus
at the end of the pT7NDVCATs, a PCR was performed
using as template pT7CATRT (unpublished), which is a
pUC19-derivate plasmid containing a T7 promoter, the 5V
noncoding region of the influenza A virus NS gene, the CAT
reporter gene, the 3V noncoding region of the influenza A
NS gene, the genomic hepatitis delta ribozyme, and the T7
RNA polymerase termination signal. The first primer
corresponds to a sequence of pUC19 that contains the NdeI
restriction site (position 183): 5V-gtgcaccatatgcggtgtg-3V.
The second primer anneals to the 5V sequence of the
ribozyme with a BbsI site added upstream so as to obtain the
correct junction when cloned into pT7NDVCAT: 5V-
ggccaagcttgaagactttggtggccggcatggtccc-3V. pT7NDVCATs
and the PCR products were digested with BbsI and NdeI,
and the digested DNAs were ligated. The resulting plasmids
were named pT7NDVCAT0RT, pT7NDVCAT1RT,
pT7NDVCAT2RT, pT7NDVCAT3RT, pT7NDVCAT4RT,
and pT7NDVCAT5RT. Only pT7NDVCAT5RT encodes
an NDV minigenome that has a length divisible by six.
NP, P, and L expression plasmids
cDNAs corresponding to the ORFs of the NP, P, and L
genes of NDV strain California were individually cloned
into the plasmid pTM1, in which transcription is mediated
by T7 RNA polymerase. For cloning the NP, the NDV viral
RNA was used as template for an RT-PCR using as first
primer an oligonucleotide containing an AflIII site (the ATG
of this site was used as the initiating codon for the NP gene)
followed by the coding sequence of NP (5V-gcgca-
cATGTCTTCCGTATTTGACGAG-3V). The second primer
contains three restriction sites (XhoI, PstI, and BglII)
followed by a sequence complementary to the first 27 nt
of the coding sequence of P (5V-cgcgctcgagctgcaGATCTQ
CCGCATCTGTAAAGGTGGCCAT-3V). The PCR product
was digested with PstI and AflIII and cloned into PstI/
NcoI-digested pTM1.
To clone P into pTM1, an RT-PCR was performed with a
primer containing an NcoI site and the 29 first coding nt of
P (5V-ggccATGGCCACCTTTACAGATGCGGAGATCGA-
3V), and a second primer with the three same restriction sites
as used for NP, followed by a sequence complementary to nt
39–22 of the M ORF (5V-cgcgctcgagctgcagatctAGAAT-
CAAAGTATAGCCC-3V). The PCR product was digested
with PstI and NcoI and cloned into pTM1 between PstI and
NcoI.
The cloning of L was performed in three steps. First, the
first third of the L ORF was amplified by RT-PCR using a
primer corresponding to the nine first codons of L with an
Nco I site upstream (5V-gcgcccATGGCGAGCTCC-GGTCCTGAAAGGGC-3V) and a second primer annealing
to nt positions 2804–2776 of L with an XmaI site in this
sequence (5V-ggCCCGGGTCACCGATATTTCTAGTGTA-
GAG-3V). The PCR product was cut with NcoI and XmaI
and cloned into pTM1 between the same sites. Second, an
RT-PCR of the last third of L between nt 4799 and 4831 was
performed using a primer in which silent mutations (in bold)
were introduced to create an XmaI site (5V-gatcCccGg-
GAAATCCCGAAAATAAGAGGCTTATCTG-3V) and a
second primer annealing to the 5V noncoding region of the
NDV genome downstream L and containing XbaI, NheI,
and SpeI restriction sites (5V-gcgctctagagctagcactagtC-
TAAGGATACAATTGGCCAGAAAAGGAGCC-3V). The
PCR was cut with XmaI and SpeI and cloned into XmaI/
SpeI-digested plasmid. The last step amplified the missing
middle portion of the L ORF by RT-PCR using two primers
corresponding to nt 2792–2821 in positive polarity (5V-
CGGTGACCCGGGGACTACTGCTTTTGCAG-3V) and to
nt 4804–4774 in negative polarity of the coding L sequence
(5V-gatcCcCggGTTGTAGCAAAGAGTACCGTGTAC-3V).
Both of them contained an XmaI site. After digestion with
XmaI, the PCR product was cloned in the previous
construction. The right orientation was selected by restric-
tion analysis.
Plasmid mutagenesis
Mutations in the 3V and 5V ends of the NDV minigenome
encoded by pT7NDVCAT5RT were made by PCR-muta-
genesis using specific primers. All mutations were con-
firmed by nucleotide sequence analysis.
Transfections and CAT assays
COS-7 cell monolayers were grown on 35-mm plates to
90% confluency and infected with vaccinia virus vTF7-3
(m.o.i. = 1) for 1h at 37 8C. The cells were subsequently
transfected with 1 Ag of minigenome plasmid, 2 Ag pTM1-
NP, 1 Ag pTM1-P, and 0.4 Ag pTM1-L, using 7 Al of
lipofectamine, essentially as described by the supplier
(GibcoBRL/LifeTechnologies). Six hours posttransfection,
the medium was removed and replaced with DMEM 10%
FCS. At 48 h posttransfection, the cells were collected,
pelleted, resuspended in Tris–HCl 0.25M, pH 7.4, and lysed
by three cycles of freezing and thawing. Cell lysates were
clarified by centrifugation at 8000 rpm for 5 min. CAT
assays were done using a standard method (Gorman et al.,
1982). Acetylated products were visualized by thin-layer
chromatography and quantified by densitometry.
Northern blots
Cytoplasmic RNA was isolated from transfected HeLa
cells using an Rneasy Kit (Qiagen). The RNA (15 Ag) was
subjected to electrophoresis in a 1.5% agarose gel contain-
ing 0.44M formaldehyde and later transferred to a positively
F. Marcos et al. / Virology 331 (2005) 396–406406charged nylon membrane (Boehringer Mannheim). Hybrid-
ization with a digoxigenin-labeled probe in standard hybrid-
ization buffer and chemiluminescent detection of the probe
was carried out as described in the bDIG System Use’s
Guide for filter HybridizationQ from Boehringer Mannheim.Acknowledgments
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